Avicanna Inc. Reports Q1 Results
Avicanna Inc. Reports FY Results
TR | OpenAI - 4o Maintains AVICANNA INC(AVCNF.US) With Hold Rating, Maintains Target Price $0.36
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know
Earnings Call Summary | AVICANNA INC(AVCNF.US) Q4 2024 Earnings Conference
Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today
Avicanna Reports Full Year 2024 Audited Financial Statement
Avicanna Announces Its 5th Medical Symposium on Cannabinoid-based Medicine
Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More
Avicanna Announces Scientific and Medical Affairs Collaboration With Vectura Fertin Pharma
Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
Avicanna Announces Medical Cannabis Real World Evidence Study Through MyMedi.ca
Avicanna Announces Closing of Non-Brokered Private Placement
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna Reports Q2 Results
Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion